reference/25591895

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25591895

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	899
issn	1365-2362 0014-2972
issueIdentifier	8
pageRange	891-899
publicationName	European Journal of Clinical Investigation
startingPage	891
bibliographicCitation	Williams A, Kenny D, Wilson D, Fagenello G, Nelson M, Dunstan F, Cockcroft J, Stuart G, Fraser AG. Effects of atenolol, perindopril and verapamil on haemodynamic and vascular function in Marfan syndrome - a randomised, double-blind, crossover trial. Eur J Clin Invest. 2012 Aug;42(8):891–9. doi: 10.1111/j.1365-2362.2012.02668.x. PMID: 22471392.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e6162ec9212046ca32d4bd70b8e9677 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2789-2216 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7b9fd198839a7370b5c3a53470f830f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_22b6a655b1bb9d6e3192fe33ffdf46b9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c4310cbe77916abf3326efb2bcf7654 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_245a604295b768bc8eae62f5ac0fab4f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a71642aaf7e7f9cab8e79ea66fad016e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eacc3f45c7aa6d14362fbdea99acc2b3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca6a1c01dea10a4797bad365e6cbccc8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0da6d62095cfaddeb9ec18ff4cf2dcc8
date	2012-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/22471392 https://doi.org/10.1111/j.1365-2362.2012.02668.x
isPartOf	https://portal.issn.org/resource/ISSN/1365-2362 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3611 https://portal.issn.org/resource/ISSN/0014-2972
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Effects of atenolol, perindopril and verapamil on haemodynamic and vascular function in Marfan syndrome – a randomised, double‐blind, crossover trial
discusses	http://id.nlm.nih.gov/mesh/M0129811 http://id.nlm.nih.gov/mesh/M0001900 http://id.nlm.nih.gov/mesh/M0001456 http://id.nlm.nih.gov/mesh/M0003165 http://id.nlm.nih.gov/mesh/M0001207 http://id.nlm.nih.gov/mesh/M0022608
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001262Q000494 http://id.nlm.nih.gov/mesh/D020913Q000494 http://id.nlm.nih.gov/mesh/D001794Q000187 http://id.nlm.nih.gov/mesh/D000959Q000494 http://id.nlm.nih.gov/mesh/D014700Q000494 http://id.nlm.nih.gov/mesh/D008382Q000188 http://id.nlm.nih.gov/mesh/D000806Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D002121Q000494 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D008382Q000503 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D006339Q000187 http://id.nlm.nih.gov/mesh/D018592
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2520 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9ffa6b56d06ddd0c9bc50088955e425b http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2249 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_360e2ece07507675dced80ba867d6dcd http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107807 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8424

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128585206 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128203001 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129233874

Total number of triples: 64.